Mohammad Othman Daoud

mohammad daoud diabetes hypoglycemia treatment clinical presentation weight loss liraglutide fasting ramadan dm pathophysiology dka diabetes emergencies hhs diabetes educators nice acc/aha dyslipidemia dpp4 inhibitors dm albiglutide glp 1ra vs meal related insulin dm algorithms glp 1 ra exenatide dm treatment barriers dcct-edic study protocol dcct-edic results microvascular complications diabetic neuropathy dm type 1 diabetic retinopathy legacy effect intensive control diabetic nephropathy insulin dcct mdi diabetes stirct control cardiovascular complications edic hyperglycemia emergencies education and training national guard course risk assessment management definitions individualization aace 2016 diabetes type 2 legacy deadly triad ukpds treatment barriers multifactorial intervention statins diabetic dyslipidemia guidelines dulaglutide hba1c reduction safety nov 14 15 jeddah ksa dr.mohammad daoud medications adjustment ramadan diabetes; medications; cardiovascular ;tecos; savo neuropathy guidelines neuropathy diabetes educatores empower dm physiology diabetes mellitus standards of care 2015 diabetes mellitus anddyslipidemia dm abcs ada 2015 diabetes mellitus and htn start insulin metformin best partners .dr.mohammad daoud